DataHow secures bridge financing to expand its digital bioprocess development solution
DataHow, a Zurich-based Swiss company specializing in AI-powered bioprocess data analytics and modeling, has closed a bridge financing round extending its Series A. The new capital will be used to accelerate real‑time and downstream expansion of its DataHowLab platform, enabling broader deployment of hybrid modelling technology across major biopharmaceutical manufacturers. Investors include Momenta, Rockwell Automation, HINA Bioventures, and Zürcher Kantonalbank, reflecting confidence in the company’s progress toward real‑time, model‑driven process control.
DataHow, a Zurich-based Swiss company specializing in AI-powered bioprocess data analytics and modeling, has closed a bridge financing round extending its Series A. The new capital will be used to accelerate real‑time and downstream expansion of its DataHowLab platform, enabling broader deployment of hybrid modelling technology across major biopharmaceutical manufacturers. Investors include Momenta, Rockwell Automation, HINA Bioventures, and Zürcher Kantonalbank, reflecting confidence in the company’s progress toward real‑time, model‑driven process control.
The funding underscores the growing role of Swiss AI in the biopharmaceutical sector, positioning DataHow as a key enabler of digital transformation and reinforcing Switzerland’s reputation for innovation in biotech and AI.
Original source record. Open the original record to verify the underlying announcement.